story of the week
De-Escalation of Disease-Modifying Therapy in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Frontiers in Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis
Front Neurol 2022 Jan 25;12(2022)799138, BL Vollmer, AB Wolf, S Sillau, JR Corboy, E AlvarezFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.